Sarah Cannon Research Institute Sarah Cannon Cancer Institute Acquires Genospace The cloud-based personalized medicine software company will stay in Cambridge, Massachusetts and will become a wholly-owned subsidiary of the institute. Foundation Medicine, Sarah Cannon Partner on Genomic Profiling for Cancer Clinical Trials Under the agreement, researchers can use Foundation Medicine's assays to select patients eligible for Sarah Cannon Research Institute's clinical studies. Drugmakers Increasingly Using Basket Trials to Gain Precision Medicine Insights, ASCO Studies Show Premium Researchers presented data suggesting that pharma companies are using basket studies to identify molecularly defined patient subsets who might benefit from their drugs. Biocept, Sarah Cannon Partner for Breast Cancer Screening The partners will explore the use of Biocept's liquid biopsy technology to identify and detect biomarkers in ER-positive breast cancer patients. At ASCO, Growing Data from NGS-guided Cancer Therapy Programs Premium CHICAGO (GenomeWeb) – Research presented at the annual meeting of the American Society of Clinical Oncology this week included a wealth of data from programs using next-generation sequencing to guide treatment for cancer patients. Jul 3, 2013 With Sarah Cannon Research Institute, AstraZeneca Genomically Profiling Patients for Drug Trials Premium Jul 1, 2013 Sarah Cannon Inks Personalized Medicine Pact with AstraZeneca May 8, 2013 UCL-AD, Sarah Cannon to Launch Cancer Panel on PGM to Select Therapy, Stratify Patients for Trials Premium Oct 17, 2012 Prospective Study Suggests Site-Specific Treatment after BioTheranostics' CUP Testing Improves Survival Premium Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.